Paid Clinical Trials and Focus Groups by Category |
|
|
|
-
860 Peachwood Drive
United States, Florida 32720
United States
Avail Clinical Research is currently screening for clinical research study for tobacco users who don't intend to quit. Up to $400 to qualified participants.
Condition: Smoking
Interventions: Behavioral: Standard Treatment Counseling; Behavioral: Culturally-Tailored Treatment
Sponsors: University of Wisconsin, Madison; University of Wisconsin, Milwaukee; Menominee Indian Tribe of Wisconsin
Recruiting - verified March 2010
Conditions: Schizophrenia; Schizoaffective Disorder
Intervention: Behavioral: Behavioural Intervention for the Prevention of Weight Gain
Sponsors: Centre for Addiction and Mental Health; Canadian Institutes of Health Research (CIHR)
Recruiting - verified March 2010
Condition: Alcoholism
Interventions: Drug: Baclofen; Drug: Cyproheptadine
Sponsor: Brown University
Recruiting - verified February 2010
Condition: Alcohol Dependence
Interventions: Drug: Varenicline; Drug: Placebo
Sponsors: Johannes Gutenberg University Mainz; Pfizer
Not yet recruiting - verified December 2009
Condition: Methamphetamine Addiction
Interventions: Other: Placebo; Drug: Rivastigmine
Sponsor: National Institute on Drug Abuse (NIDA)
Recruiting - verified March 2010
Condition: Methamphetamine Dependence
Intervention: Behavioral: Intensive Motivational Interviewing
Sponsor: Public Health Institute, California
Recruiting - verified February 2010
Conditions: Cocaine Dependence; Methamphetamine Dependence; Nicotine Dependence
Intervention: Other: Smoking-cessation treatment
Sponsors: University of Cincinnati; National Institute on Drug Abuse (NIDA)
Recruiting - verified February 2010
Condition: Pancreatitis
Interventions: Drug: Precedex; Drug: sodium chlorid 0,9%
Sponsor: Helsinki University Central Hospital
Recruiting - verified August 2009
Conditions: Alcohol Dependence; Problematic Drinking; Hazardous Drinking; Human Immunodeficiency Virus; Acquired Immunodeficiency Syndrome
Interventions: Drug: Vivitrol- Intramuscular naltrexone (depot-formulation); Drug: Placebo
Sponsors: Yale University; National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Not yet recruiting - verified February 2010
Condition: Methamphetamine Addiction
Interventions: Drug: Perindopril; Other: Placebo
Sponsors: Baylor College of Medicine; National Institute on Drug Abuse (NIDA)
Recruiting - verified March 2010
Condition: Cocaine Addiction
Interventions: Drug: Sugar Pill; Drug: Doxazosin
Sponsors: Baylor College of Medicine; National Institute on Drug Abuse (NIDA)
Recruiting - verified March 2010
Condition: Nicotine Addiction
Interventions: Drug: Cycloserine; Drug: Placebo
Sponsors: Baylor College of Medicine; National Institute on Drug Abuse (NIDA)
Recruiting - verified March 2010
Condition: Methamphetamine Addiction
Interventions: Drug: Placebo (Solution without NAC); Drug: N-acetylcysteine; Drug: N-Acetylcysteine
Sponsors: Baylor College of Medicine; National Institute on Drug Abuse (NIDA)
Not yet recruiting - verified March 2010
Condition: Drug Abuse
Intervention:
Sponsor: National Institute on Drug Abuse (NIDA)
Not yet recruiting - verified June 2009
Conditions: Nicotine Dependence; Drug Abuse
Intervention:
Sponsor: National Institute on Drug Abuse (NIDA)
Recruiting - verified January 2009
Condition: Nicotine Dependence
Intervention: Device: Transcranial Magnetic Stimulation
Sponsor: National Institute on Drug Abuse (NIDA)
Recruiting - verified February 2010
Condition: Substance Use Disorders
Intervention:
Sponsor: National Institute on Drug Abuse (NIDA)
Recruiting - verified April 2009
Conditions: Cocaine Dependence; Cannabis Dependence; Schizophrenia
Intervention:
Sponsor: National Institute on Drug Abuse (NIDA)
Recruiting - verified July 2009
Condition: Cannabis Use
Intervention: Device: Repetitive Transcranial Magnetic Stimulation
Sponsor: National Institute on Drug Abuse (NIDA)
Not yet recruiting - verified January 2010
Condition: Alcohol Dependence
Intervention: Behavioral: Addiction CHESS
Sponsors: University of Wisconsin, Madison; National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Recruiting - verified March 2010
Conditions: Depressive Symptoms; Substance-Related Disorders; Posttraumatic Stress Disorders
Interventions: Behavioral: ICBT: Integrated Cognitive Behavioral Therapy; Behavioral: CPT-M: Cognitive Processing Therapy-Modified
Sponsor: Department of Veterans Affairs
Not yet recruiting - verified March 2010
Condition: Alcoholism
Interventions: Drug: Ethanol; Drug: Placebo; Drug: Diphenhydramine; Drug: Caffeine
Sponsors: University of Chicago; National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Recruiting - verified March 2010
Conditions: Attention Deficit Hyperactivity Disorder; Nicotine Dependence; Cannabis Use Disorder
Intervention: Drug: Bupropion, Cognitive Behavioral Therapy
Sponsor: National Institute on Drug Abuse (NIDA)
Recruiting - verified February 2010
Condition: Pathological Gambling
Intervention: Drug: Tolcapone
Sponsor: University of Minnesota - Clinical and Translational Science Institute
Recruiting - verified March 2010
Condition: Tardive Dyskinesia
Interventions: Drug: Pyridoxal 5'-Phosphate; Drug: Placebo
Sponsor: Medicure
Recruiting - verified February 2010
Conditions: Cocaine Addiction; Cocaine Abuse
Intervention:
Sponsor: National Institute on Drug Abuse (NIDA)
Not yet recruiting - verified January 2010
Condition: Schizophrenia
Interventions: Behavioral: Cognitive Behavioral Social Skills Training (CBSST) plus treatment as usual; Behavioral: Treatment as usual (TAU)
Sponsor: Centre for Addiction and Mental Health
Recruiting - verified March 2010
Condition: Cocaine Dependence
Interventions: Drug: Propranolol; Drug: Placebo
Sponsors: University of South Carolina; National Institute on Drug Abuse (NIDA)
Recruiting - verified March 2010
Conditions: Schizophrenia; Schizoaffective Disorder; Schizophreniform Disorder
Intervention: Drug: risperidone
Sponsor: Centre for Addiction and Mental Health
Recruiting - verified March 2010
Conditions: Schizophrenia; Schizoaffective Disorder
Intervention: Drug: ziprazidone
Sponsors: Centre for Addiction and Mental Health; Pfizer
Recruiting - verified March 2010
Condition: Mental Disorder
Intervention: Behavioral: Adding a Consumer Provider to Intensive Case Management Teams (called MHICM in the VA)
Sponsor: Department of Veterans Affairs
Recruiting - verified March 2010
Conditions: Schizophrenia; Schizoaffective Disorder; Schizophreniform Disorder; Delusional Disorder; Psychotic Disorder
Intervention: Drug: Risperidone and PET scans
Sponsor: Centre for Addiction and Mental Health
Recruiting - verified March 2010
Condition: Methamphetamine Dependence
Interventions: Drug: Bupropion; Other: Placebo
Sponsor: National Institute on Drug Abuse (NIDA)
Recruiting - verified March 2010
Conditions: Hedgehog Pathway; Smoothened; Basal Cell Carcinoma (BCC); Basal Cell Nevoid Syndrome (BCNS)
Intervention: Drug: BMS-833923 (XL139)
Sponsors: Bristol-Myers Squibb; Exelixis
Recruiting - verified October 2009
Condition: Major Depressive Disorder
Interventions: Device: transcranial direct current stimulation (tDCS); Device: Sham treatment
Sponsor: Centre for Addiction and Mental Health
Recruiting - verified March 2010
Condition: Marijuana Abuse
Interventions: Behavioral: Motivational Enhancement Therapy (MET)/CBT+CM; Behavioral: Motivational Enhancement Therapy (MET)/CBT+CM; Behavioral: Motivational Enhancement Therapy (MET)/CBT
Sponsors: University of Arkansas; National Institutes of Health (NIH)
Recruiting - verified March 2010
Condition: Obsessive Compulsive Disorder
Interventions: Device: refractory transcranial magnetic stimulation (rTMS); Device: Sham condition
Sponsor: Centre for Addiction and Mental Health
Recruiting - verified February 2010
Condition: Smoking
Interventions: Drug: nicotine replacement; Behavioral: behavioural intervention
Sponsors: Centre for Addiction and Mental Health; Pfizer; Ontario Ministry of Health and Long Term Care
Recruiting - verified March 2010